Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.6253
-0.0344 (-5.21%)
At close: Jul 25, 2025, 4:00 PM
0.6256
+0.0003 (0.05%)
After-hours: Jul 25, 2025, 4:00 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $53.88 million as of July 25, 2025. Its market cap has decreased by -73.32% in one year.
Market Cap
53.88M
Enterprise Value
-58.74M
1-Year Change
-73.32%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $53.88M, a decrease of -94.87%. That is a compound annual growth rate of -51.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 56.84M | -33.82% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.04B |
| Johnson & Johnson | 404.05B |
| AbbVie | 330.51B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 258.65B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 218.75B |
| AstraZeneca | 216.82B |